Annual Working Capital:
$32.92M+$14.64M(+80.08%)Summary
- As of today, AKBA annual working capital is $32.92 million, with the most recent change of +$14.64 million (+80.08%) on December 31, 2024.
- During the last 3 years, AKBA annual working capital has risen by +$22.82 million (+225.98%).
- AKBA annual working capital is now -84.85% below its all-time high of $217.25 million, reached on December 31, 2017.
Performance
AKBA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Working Capital:
$115.94M+$3.38M(+3.01%)Summary
- As of today, AKBA quarterly working capital is $115.94 million, with the most recent change of +$3.38 million (+3.01%) on June 1, 2025.
- Over the past year, AKBA quarterly working capital has increased by +$111.14 million (+2316.93%).
- AKBA quarterly working capital is now -59.40% below its all-time high of $285.56 million, reached on March 31, 2018.
Performance
AKBA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
AKBA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +80.1% | +2316.9% |
| 3Y3 Years | +226.0% | +64.5% |
| 5Y5 Years | -67.5% | -54.2% |
AKBA Working Capital Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -40.9% | +226.0% | at high | +2316.9% |
| 5Y | 5-Year | -82.1% | +226.0% | -44.7% | +2316.9% |
| All-Time | All-Time | -84.8% | +1328.5% | -59.4% | +4427.1% |
AKBA Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $115.94M(+3.0%) |
| Mar 2025 | - | $112.56M(+241.9%) |
| Dec 2024 | $32.92M(+80.1%) | $32.92M(-4.3%) |
| Sep 2024 | - | $34.41M(+617.3%) |
| Jun 2024 | - | $4.80M(-89.7%) |
| Mar 2024 | - | $46.46M(+154.2%) |
| Dec 2023 | $18.28M(-67.2%) | $18.28M(-38.9%) |
| Sep 2023 | - | $29.90M(+13.8%) |
| Jun 2023 | - | $26.26M(-30.5%) |
| Mar 2023 | - | $37.77M(-32.1%) |
| Dec 2022 | $55.65M(+451.1%) | $55.65M(+12.3%) |
| Sep 2022 | - | $49.55M(-29.7%) |
| Jun 2022 | - | $70.48M(+44.5%) |
| Mar 2022 | - | $48.77M(+383.0%) |
| Dec 2021 | $10.10M(-94.5%) | $10.10M(-92.8%) |
| Sep 2021 | - | $140.88M(-14.9%) |
| Jun 2021 | - | $165.48M(-14.0%) |
| Mar 2021 | - | $192.34M(+4.4%) |
| Dec 2020 | $184.29M(+81.7%) | $184.29M(-12.1%) |
| Sep 2020 | - | $209.54M(-17.3%) |
| Jun 2020 | - | $253.33M(+100.1%) |
| Mar 2020 | - | $126.60M(+24.8%) |
| Dec 2019 | $101.42M | $101.42M(+33.7%) |
| Sep 2019 | - | $75.86M(-42.0%) |
| Jun 2019 | - | $130.78M(-9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $144.62M(-28.6%) |
| Dec 2018 | $202.58M(-6.8%) | $202.58M(-8.0%) |
| Sep 2018 | - | $220.13M(-9.4%) |
| Jun 2018 | - | $243.00M(-14.9%) |
| Mar 2018 | - | $285.56M(+31.4%) |
| Dec 2017 | $217.25M(+19.3%) | $217.25M(+19.0%) |
| Sep 2017 | - | $182.58M(+21.1%) |
| Jun 2017 | - | $150.80M(+24.0%) |
| Mar 2017 | - | $121.59M(-33.2%) |
| Dec 2016 | $182.05M(+41.0%) | $182.05M(+31.0%) |
| Sep 2016 | - | $139.01M(-19.0%) |
| Jun 2016 | - | $171.59M(-16.8%) |
| Mar 2016 | - | $206.12M(+59.6%) |
| Dec 2015 | $129.15M(+24.7%) | $129.15M(-10.7%) |
| Sep 2015 | - | $144.64M(-3.0%) |
| Jun 2015 | - | $149.06M(+58.8%) |
| Mar 2015 | - | $93.85M(-9.4%) |
| Dec 2014 | $103.59M(+250.8%) | $103.59M(-8.6%) |
| Sep 2014 | - | $113.32M(-6.6%) |
| Jun 2014 | - | $121.28M(-5.0%) |
| Mar 2014 | - | $127.62M(+332.2%) |
| Dec 2013 | $29.53M(+1202.1%) | $29.53M(+1202.1%) |
| Dec 2012 | -$2.68M(-149.7%) | - |
| Dec 2012 | - | -$2.68M |
| Dec 2011 | $5.39M | - |
FAQ
- What is Akebia Therapeutics, Inc. annual working capital?
- What is the all-time high annual working capital for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual working capital year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly working capital?
- What is the all-time high quarterly working capital for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly working capital year-on-year change?
What is Akebia Therapeutics, Inc. annual working capital?
The current annual working capital of AKBA is $32.92M
What is the all-time high annual working capital for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual working capital is $217.25M
What is Akebia Therapeutics, Inc. annual working capital year-on-year change?
Over the past year, AKBA annual working capital has changed by +$14.64M (+80.08%)
What is Akebia Therapeutics, Inc. quarterly working capital?
The current quarterly working capital of AKBA is $115.94M
What is the all-time high quarterly working capital for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly working capital is $285.56M
What is Akebia Therapeutics, Inc. quarterly working capital year-on-year change?
Over the past year, AKBA quarterly working capital has changed by +$111.14M (+2316.93%)